Got change? There’s a coin shortage because of coronavirus stopping the flow of physical currency

Finance

Jamie Grill | JGI | Getty Images

This is breaking news. Please check back for updates.

Federal Reserve Chairman Jerome Powell told Congress on Wednesday that the circulation of physical coinage ground to a halt amid the coronavirus outbreak but that the central bank is working to fix the flow.

The topic came to light after Rep. John Rose, R-Tenn., said banks in Tennessee are reporting that they’re receiving smaller-than-usual sums of coinage each week. Rose asked Powell if the central bank was aware of any shortages in the production and distribution of currency, and if there are plans to boost the allocations to their usual levels. 

“What’s happened is, with the partial closure of the economy, the flow of coins through the economy has … kind of stopped. The places where you’d go to give your coins and get credit … those have not been working,” Powell said.

“So, a whole system of flow has kind of come to a stop. We’re well aware of this: We’re working with the mint and we’re working with the Reserve banks. And as the economy reopens, we’re seeing coins begin to move around again,” he added.

The spread of Covid-19 across the U.S. over the first half of the year has led to a rise in contactless payments as more American shelter in place and shop online using PayPal or credit cards. 

Powell testified before the House Financial Services Comittee on Wendesday as part of his semiannual testimony to Congress. He warned the Senate Banking Committee on Tuesday of “significant uncertainty” about the economy’s recovery from the coronavirus and said small businesses are at risk.

Subscribe to CNBC PRO for exclusive insights and analysis, and live business day programming from around the world.

Articles You May Like

Eli Lilly’s quarter was messy. What to do with the stock is more clear-cut
Watch maker Patek Philippe launches first new collection in 25 years
‘Slow shopping’ can save you money this holiday season. Here’s how it works
We’re hiking our GEHC price target, looking beyond a mixed quarter to next year’s catalysts
Novo Nordisk’s Ozempic and Wegovy now available in the U.S. after shortages, FDA says

Leave a Reply

Your email address will not be published. Required fields are marked *